RT Book, Section
A1 Rucker, N. Lee
A2 Angaran, David M.
A2 Whalen, Karen
SR Print(0)
ID 1102487576
T1 Medicare Part D's Medication Therapy Management: Shifting from Neutral to Drive
T2 Medication Therapy Management: A Comprehensive Approach
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071848695
LK accesspharmacy.mhmedical.com/content.aspx?aid=1102487576
RD 2024/04/18
AB Participation  in  Part  D  medication  therapy  management  (MTM)  programs  is  lower  than  predicted,  and  this  has  frustrated  Part  D  plan  sponsors  and  the  federal  government,  especially  considering  MTM's  success  in  some  Medicaid  and  private  sector  programs.MTM  is  defined  as  a  systematic  process  of  collecting  patient-specific  information,  assessing  medication  therapies  to  identify  and  prioritize  medication-related  problems,  and  creating  a  plan  to  resolve  them.MTM's  scope  of  services  within  Part  D  is  evolving.  This  requires  constant  surveillance  of  the  literature  and  CMS  communications.Under  Part  D,  free  MTM  services  are  generally  reserved  for  enrollees  who  meet  criteria  related  to  their  annual  Part  D  drug  costs,  number  of  prescription  drugs,  and  prevalence  of  certain  chronic  diseases.MTM  is  showing  promise  in  other  non-Medicare  drug  benefit  programs.The  Patient  Protection  and  Affordable  Care  Act  (P.L.  111-148)  authorized  grants  for  "medication  management  services"  in  all  practice  settings  (Section  3503),  noting  that  such  services  will  help  manage  chronic  disease,  reduce  medical  errors,  and  improve  patient  adherence  to  therapies  while  reducing  acute  care  costs  and  hospital  readmissions.  However,  funds  were  never  appropriated  for  this  section.Part  D's  inherent  structure  makes  it  particularly  challenging  to  create  and  sustain  robust  MTM  programs.  However,  CMS  research  (2013)  identified  effective  MTM  practices  of  highly-effective  drug  plans.